4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001214659-20-005339
Chief Innovation/Tech Officer gave up 4,132 shares (to pay taxes)
- Chief Innovation/Tech Officer acquired 14,572 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schobel Alexander Mark · Chief Innovation/Tech Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-31 | Exercise or conversion : show line 1 in the form | +14,572 | 916,685 | D | ||
| 2020-05-31 | Shares withheld for taxes : show line 2 in the form | −4,132 | $4.87 | $20,123 | 912,553 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-31 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −14,572 | 0 | D |
Loading xslF345X03/marketforms-48951.xml…